These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

435 related articles for article (PubMed ID: 28807511)

  • 21. Usefulness of CHADS2 and CHA2DS2-VASc Scores in the Prediction of New-Onset Atrial Fibrillation: A Population-Based Study.
    Saliba W; Gronich N; Barnett-Griness O; Rennert G
    Am J Med; 2016 Aug; 129(8):843-9. PubMed ID: 27012854
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CHA2DS2-VASc score is directly associated with the risk of pulmonary embolism in patients with atrial fibrillation.
    Saliba W; Rennert G
    Am J Med; 2014 Jan; 127(1):45-52. PubMed ID: 24384101
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Validation of a Modified CHA2DS2-VASc Score for Stroke Risk Stratification in Asian Patients With Atrial Fibrillation: A Nationwide Cohort Study.
    Chao TF; Lip GY; Liu CJ; Tuan TC; Chen SJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Chen TJ; Chiang CE; Chen SA
    Stroke; 2016 Oct; 47(10):2462-9. PubMed ID: 27625386
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Performance of the CHA
    Pieralli F; Biondo B; Vannucchi V; Falcone M; Antonielli E; De Marzi G; Casati C; Maddaluni L; Nozzoli C; Olivotto I
    Eur J Intern Med; 2019 Apr; 62():24-28. PubMed ID: 30692019
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Is an Oral Anticoagulant Necessary for Young Atrial Fibrillation Patients With a CHA2DS2-VASc Score of 1 (Men) or 2 (Women)?
    Hung Y; Chao TF; Liu CJ; Tuan TC; Lin YJ; Chang SL; Lo LW; Hu YF; Liao JN; Chung FP; Lin WY; Lin WS; Cheng SM; Chen TJ; Lip GY; Chen SA
    J Am Heart Assoc; 2016 Oct; 5(10):. PubMed ID: 27702803
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ischemic Stroke Risk in Patients With Atrial Fibrillation and CHA2DS2-VASc Score of 1: Systematic Review and Meta-Analysis.
    Joundi RA; Cipriano LE; Sposato LA; Saposnik G;
    Stroke; 2016 May; 47(5):1364-7. PubMed ID: 27026630
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [A study on the evaluation of anticoagulation status comparing of CHADS2 versus CHA2DS2-VASc scores in patients with non valvular atrial fibrillation in Xinjiang area].
    Song SF; Zhou XH; Ruozha B; Wu M; Li YD; Zhang JH; Xing Q; Lu YM; Tang BP
    Zhonghua Nei Ke Za Zhi; 2016 Sep; 55(9):684-8. PubMed ID: 27586975
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The value of the CHA2DS2-VASc score for refining stroke risk stratification in patients with atrial fibrillation with a CHADS2 score 0-1: a nationwide cohort study.
    Olesen JB; Torp-Pedersen C; Hansen ML; Lip GY
    Thromb Haemost; 2012 Jun; 107(6):1172-9. PubMed ID: 22473219
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of CHA
    van Doorn S; Rutten FH; O'Flynn CM; Oudega R; Hoes AW; Moons KGM; Geersing GJ
    Int J Cardiol; 2018 Dec; 273():123-129. PubMed ID: 30224261
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The thromboembolism risk of low-risk atrial fibrillation patients with different clinical characteristics].
    Liu XB; Jia ZX; Xia SJ; He L; Lu SX; Guo XY; Li SN; Liu N; Jiang CX; Sang CH; Tang RB; Long DY; Yu RH; Bai R; Wu JH; Du X; Dong JZ; Ma CS
    Zhonghua Xin Xue Guan Bing Za Zhi; 2020 Sep; 48(9):735-739. PubMed ID: 32957755
    [No Abstract]   [Full Text] [Related]  

  • 31. Comparison of CHA
    Hu WS; Lin CL
    Atherosclerosis; 2017 Nov; 266():205-211. PubMed ID: 29049919
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Additional value of left atrial appendage geometry and hemodynamics when considering anticoagulation strategy in patients with atrial fibrillation with low CHA
    Lee JM; Kim JB; Uhm JS; Pak HN; Lee MH; Joung B
    Heart Rhythm; 2017 Sep; 14(9):1297-1301. PubMed ID: 28559088
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Use of Oral Anticoagulation in a Real-World Population With Device Detected Atrial Fibrillation.
    Kaplan RM; Ziegler PD; Koehler J; Landman S; Sarkar S; Passman RS
    J Am Heart Assoc; 2020 Dec; 9(24):e018378. PubMed ID: 33252286
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The CHA
    Beyer-Westendorf J; Kreutz R; Posch F; Ay C
    Int J Cardiol; 2018 Feb; 253():71-77. PubMed ID: 29306476
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CHA2DS2-VASc score and fibrinogen concentration in patients with atrial fibrillation.
    Semczuk-Kaczmarek K; Płatek AE; Ryś A; Adamowicz J; Legosz P; Kotkowski M; Dudzik-Płocica A; Gorko D; Szymański FM; Filipiak KJ
    Adv Clin Exp Med; 2019 Nov; 28(11):1451-1457. PubMed ID: 31596555
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Should atrial fibrillation patients with 1 additional risk factor of the CHA2DS2-VASc score (beyond sex) receive oral anticoagulation?
    Chao TF; Liu CJ; Wang KL; Lin YJ; Chang SL; Lo LW; Hu YF; Tuan TC; Chen TJ; Lip GY; Chen SA
    J Am Coll Cardiol; 2015 Feb; 65(7):635-42. PubMed ID: 25677422
    [TBL] [Abstract][Full Text] [Related]  

  • 37. CHA
    Harb SC; Wang TKM; Nemer D; Wu Y; Cho L; Menon V; Wazni O; Cremer PC; Jaber W
    Open Heart; 2021 Nov; 8(2):. PubMed ID: 34815301
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Young Male Patients with Atrial Fibrillation and CHA2DS2-VASc Score of 1 May Not Need Anticoagulants: A Nationwide Population-Based Study.
    Chan YH; Wu LS; Chang SH; Lee HF; Liu JR; See LC; Yeh YH; Kuo CT
    PLoS One; 2016; 11(3):e0151485. PubMed ID: 26986069
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Role of CHA
    Hu WS; Lin CL
    BMJ Open; 2018 Mar; 8(3):e020065. PubMed ID: 29567851
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Net clinical benefit of warfarin in individuals with atrial fibrillation across stroke risk and across primary and secondary care.
    Allan V; Banerjee A; Shah AD; Patel R; Denaxas S; Casas JP; Hemingway H
    Heart; 2017 Feb; 103(3):210-218. PubMed ID: 27580623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.